Table E1.
Demographic characteristics and clinical summary
| Patient | Age (y) | Sex | BMI (kg/m2) | Race | Comorbidities | Symptoms on admission | DOI on admission | Treatments received | ICU stay | Oxygen support | DOI on discharge |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10 | M | 16.74 | White (non-Hispanic) | Hereditary spherocytosis | Fever Cough Chest pain |
11 | Amoxicillin Azithromycin Ceftriaxone Cefepime Sulfamethoxazole-trimethoprim Vancomycin Remdesivir Enoxaparin IVIG Convalescent plasma |
No | Nasal cannula | 29 |
| 2 | 24 | M | 21.74 | White (Hispanic) | Chronic sinusitis Bronchiectasis Left hip dysplasia Recurrent C difficile colitis Recurrent Helicobacter skin infections |
Fever Chills Cough Chest pain Bodyaches Fatigue Diarrhea |
13 | Doxycycline Ertapenem Vancomycin Heparin IVIG Convalescent plasma |
No | Room air | 19 |
| 3 | 40 | M | 22.7 | White (non-Hispanic) | Chronic sinusitis | Fever Coughs Dyspnea on exertion Chills Weight loss |
42 | Azithromycin IVIG Convalescent plasma |
No | Nasal cannula | 45 |
BMI, Body mass index; DOI, day of illness; ICU, intensive care unit.
The demographic characteristics, BMI, past medical history, symptoms on presentation, length of illness before presentation, therapies in addition to convalescent plasma, length of illness to discharge, ICU stay, and day of illness on discharge are summarized above.